VIVANI MED.INC. NEW O.N. Market Cap ($79.34 Million)
Market Cap & Net Worth: VIVANI MED.INC. NEW O.N. (U5P)
VIVANI MED.INC. NEW O.N. market cap. VIVANI MED.INC. NEW O.N. (F:U5P) has a market capitalization of $79.34 Million (€67.86 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #19918 globally and #1824 in its home market, demonstrating a -1.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VIVANI MED.INC. NEW O.N.'s stock price €0.93 by its total outstanding shares 86235104 (86.24 Million). Also see U5P cash flow metrics for how efficiently the company converts equity into cash flow.
VIVANI MED.INC. NEW O.N. Market Cap History (2015–2026)
VIVANI MED.INC. NEW O.N. market cap history from 2015 to 2026. Data shows change from $569.42 Million to $93.26 Million (-16.49% CAGR). Check U5P stock price and chart for real-time trading data and today's change.
VIVANI MED.INC. NEW O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VIVANI MED.INC. NEW O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore VIVANI MED.INC. NEW O.N. net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of U5P by Market Capitalization
Companies near VIVANI MED.INC. NEW O.N. in the global market cap rankings as of November 4, 2026. Also see VIVANI MED.INC. NEW O.N. assets under control for a full breakdown of the balance sheet.
Key companies related to VIVANI MED.INC. NEW O.N. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of VIVANI MED.INC. NEW O.N. (2015–2026)
Market capitalization of VIVANI MED.INC. NEW O.N. from 2015 to today. Between 2015 and today, VIVANI MED.INC. NEW O.N.'s market cap moved from $569.42 Million to $ 93.26 Million, with a yearly change of -16.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €93.26 Million | -4.64% |
| 2025 | €97.79 Million | -6.73% |
| 2024 | €104.85 Million | +13.04% |
| 2023 | €92.75 Million | +14.29% |
| 2022 | €81.16 Million | -45.24% |
| 2021 | €148.20 Million | -22.63% |
| 2020 | €191.55 Million | +192.31% |
| 2019 | €65.53 Million | -9.72% |
| 2018 | €72.59 Million | -57.87% |
| 2017 | €172.30 Million | -9.82% |
| 2016 | €191.05 Million | -66.45% |
| 2015 | €569.42 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of VIVANI MED.INC. NEW O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $79.34 Million USD |
| MoneyControl | $79.34 Million USD |
| MarketWatch | $79.34 Million USD |
| marketcap.company | $79.34 Million USD |
| Reuters | $79.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About VIVANI MED.INC. NEW O.N.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the t… Read more